Effect of semaglutide on alanine aminotransferase in subjects with type 2 diabetes and high cardiovascular risk

被引：0
|
作者：
Sanyal, Arun J. [1 ]
Hansen, Morten [2 ]
Linder, Martin [2 ]
Newsome, Philip N. [3 ]
机构：
[1] Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Internal Med, Richmond, VA USA
[2] Novo Nordisk AS, Soborg, Denmark
[3] Queen Elizabeth Hosp Birmingham, Liver Unit, Birmingham, W Midlands, England
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2220
引用
收藏
页码：1175A / 1175A
页数：1
相关论文
共 50 条
  • [31] Effect of upper gastrointestinal disease on the pharmacokinetics of oral semaglutide in subjects with type 2 diabetes
    Meier, Juris J.
    Granhall, Charlotte
    Hoevelmann, Ulrike
    Navarria, Andrea
    Plum-Moerschel, Leona
    Ramesh, Chethana
    Tannapfel, Andrea
    Kapitza, Christoph
    [J]. DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 684 - 692
  • [32] Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity
    Newsome, Philip
    Francque, Sven
    Harrison, Stephen
    Ratziu, Vlad
    Van Gaal, Luc
    Calanna, Salvatore
    Hansen, Morten
    Linder, Martin
    Sanyal, Arun
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (02) : 193 - 203
  • [33] Dietary phylloquinone intake and risk of type 2 diabetes in elderly subjects at high risk of cardiovascular disease
    Ibarrola-Jurado, Nuria
    Salas-Salvado, Jordi
    Martinez-Gonzalez, Miguel A.
    Bullo, Monica
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2012, 96 (05): : 1113 - 1118
  • [34] SUSTAIN 6: A POST-HOC ANALYSIS OF THE EFFECT OF SEMAGLUTIDE ON CARDIOVASCULAR OUTCOMES OVER TIME IN SUBJECTS WITH TYPE 2 DIABETES
    Bellary, S.
    Jodar, E.
    Seufert, J.
    Damgaard, L. H.
    Holst, A. Gaarsdal
    Leiter, L.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2018, 34 : E6 - E7
  • [35] The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment
    Weng, Stephen F.
    Kai, Joe
    Guha, Indra Neil
    Qureshi, Nadeem
    [J]. OPEN HEART, 2015, 2 (01):
  • [36] SUSTAIN 6: a post-hoc analysis of the effect of semaglutide on cardiovascular outcomes over time in subjects with type 2 diabetes
    Jodar, E.
    Seufert, J.
    Damgaard, L. H.
    Holst, A. G.
    Leiter, L. A.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 : 819 - 819
  • [37] Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
    Husain, Mansoor
    Birkenfeld, Andreas L.
    Donsmark, Morten
    Dungan, Kathleen
    Eliaschewitz, Freddy G.
    Franco, Denise R.
    Jeppesen, Ole K.
    Lingvay, Ildiko
    Mosenzon, Ofri
    Pedersen, Sue D.
    Tack, Cees J.
    Thomsen, Mette
    Vilsboll, Tina
    Warren, Mark L.
    Bain, Stephen C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (09): : 841 - 851
  • [38] Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes reply
    Husain, Mansoor
    Donsmark, Morten
    Bain, Stephen C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 2076 - 2077
  • [39] INDEPENDENT EFFECTS OF TYPE 2 DIABETES AND OBESITY ON CARDIOPULMONARY PERFORMANCE IN SUBJECTS AT HIGH CARDIOVASCULAR RISK
    Nesti, L.
    Pugliese, N.
    Armenia, S.
    De Biase, N.
    Balletti, A.
    Trico, D.
    Natali, A.
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25
  • [40] Adipokines and inflammatory markers in elderly subjects with high risk of type 2 diabetes and cardiovascular disease
    Saukkonen, Tuula
    Mutt, Shivaprakash Jagalur
    Jokelainen, Jari
    Saukkonen, Anna-Maria
    Raza, Ghulam Shere
    Karhu, Toni
    Harkonen, Pirjo
    Eckel, Juergen
    Herzig, Karl-Heinz
    Rajala, Ulla
    Keinanen-Kiukaanniemi, Sirkka
    [J]. SCIENTIFIC REPORTS, 2018, 8
12345